Current evidence for histone deacetylase inhibitors in pancreatic cancer.
about
Cancer of the Pancreas: Molecular Pathways and Current Advancement in TreatmentDNA methyltransferases: a novel target for prevention and therapy.STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsHistone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and PerspectivesHistone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survivalThe Histone Deacetylase Gene Rpd3 Is Required for Starvation Stress ResistanceMechanisms of radiation toxicity in transformed and non-transformed cellsSuppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.Nutrients and the Pancreas: An Epigenetic Perspective.The enhanced apoptosis and antiproliferative response to combined treatment with valproate and nicotinamide in MCF-7 breast cancer cells.The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
P2860
Q26740619-A591C9D0-581E-4B42-8F11-0B5B07A29189Q33579896-D859D3AD-3DCF-49D6-AB67-3C507CDE2ADFQ33757027-B8725323-4F84-487C-82EF-862A4DABF334Q33801377-FADDA8AF-4B7B-45F5-8B93-B700A3DFA0CBQ35744910-19E5BE88-EDB6-410B-9978-1DA60F0BC77CQ35821733-E36B3FB4-F783-45F2-9025-5FCEAABE3529Q36210184-CD33A089-E153-4F22-B84B-AD6B1D4CA642Q37139115-6E978D73-4790-4107-8C37-99894ED58AC5Q37447349-F750858C-BCE2-4EDE-8783-5DF52173D3C5Q37726658-C1C9343E-6DBE-4D1A-813B-F6ECB1A08BA0Q37729841-665018E7-4F4C-453E-83E0-C6D3EDE28ED0Q39064829-8AFBB98F-2E71-49DA-9D19-B25CF5F565B8Q46280254-2C30A70C-0DFF-40D8-8250-7C4EAA30D981Q46697939-F7D46080-9877-466A-8ED1-48746356D138
P2860
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@ast
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@en
type
label
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@ast
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@en
prefLabel
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@ast
Current evidence for histone deacetylase inhibitors in pancreatic cancer.
@en
P2093
P2860
P356
P1476
Current evidence for histone deacetylase inhibitors in pancreatic cancer
@en
P2093
Efstratios Patsouris
Ioannis Koutsounas
Stamatios Theocharis
P2860
P304
P356
10.3748/WJG.V19.I6.813
P407
P577
2013-02-01T00:00:00Z